International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 12,000 shares changing hands.
International Stem Cell Stock Down 8.4 %
The firm has a market cap of $909,600.00, a PE ratio of -1.42 and a beta of 0.17. The firm’s 50 day moving average is $0.09 and its 200-day moving average is $0.08.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- How to Evaluate a Stock Before BuyingÂ
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
- What Are Trending Stocks? Trending Stocks Explained
- 3 Stocks With Rising Prices That Are Likely to Split in 2025
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
